HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment and Control (UG3/UH3)

This FOA will support biphasic (i.e., two stage, multi-method) research projects that inform community response and promote comprehensive, integrated approaches to prevent HIV and hepatitis C virus (HCV) infection, along with associated comorbidities such as hepatitis B virus (HBV) infection and sexually

transmitted diseases (STDs), among people who inject drugs (PWID) in rural US communities.

Opioid injection and its consequences (e.g., HIV, HCV, HBV, STDs and overdose) are the primary foci here.

These projects should yield evidence of the effectiveness of community response models and best practices in responding to opioid injection epidemics that can be implemented by public health systems in similar rural communities in the US.
Related Programs

Adult Viral Hepatitis Prevention and Control

Department of Health and Human Services


Drug Abuse and Addiction Research Programs

Department of Health and Human Services


HIV Demonstration, Research, Public and Professional Education Projects

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: National Institutes of Health

Estimated Funding: Not Available


Who's Eligible


Relevant Nonprofit Program Categories

G02.04
Cancer
G02.13.02
Hepatitis
G02.13.03
HIV/AIDS




Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-17-014.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-17-014.html

Contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV

Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Agency Email:
FBOWebmaster@OD.NIH.GOV

Date Posted:
2016-10-06

Application Due Date:
2017-01-10

Archive Date:
2017-02-10


Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.






More Federal Domestic Assistance Programs


Peace Corps Global Health and PEPFAR Initiative Program | Small Business Teaming Pilot Program | Water Protection Grants to the States | International Programs to Combat Human Trafficking | Green and Healthy Housing Technical Studies Grants |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders